Ardelyx Inc (ARDX)

Apr 05, 2026

Ardelyx, Inc. (ARDX) stock price, news, quote and history - Yahoo Finance UK

Apr 05, 2026

Apr 05, 2026

Could Ardelyx’s New CMO Reframe ARDX’s Long-Term Nephrology Pipeline Strategy? - Sahm

Apr 05, 2026

Apr 04, 2026

Is Ardelyx (ARDX) Offering Long-Term Value After Recent Share Price Swings? - Yahoo Finance

Apr 04, 2026

Apr 04, 2026

Ardelyx CMO Appointment Tests Growth Plans For Tenapanor Based Therapies - Yahoo Finance

Apr 04, 2026

Apr 04, 2026

Ardelyx names Rajani Dinavahi as CMO - The Pharma Letter

Apr 04, 2026

Apr 03, 2026

Ardelyx, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Apr 03, 2026

Apr 03, 2026

Ardelyx (ARDX) CMO details 301,000 options at $6.11 and 201,000 shares - stocktitan.net

Apr 03, 2026

Apr 03, 2026

Ardelyx President and CEO Sells 41,000 Shares for $243,000 - Yahoo Finance

Apr 03, 2026

Apr 03, 2026

Ardelyx President and CEO Sells 41,000 Shares for $243,000 - The Motley Fool

Apr 03, 2026

Apr 03, 2026

ARDX PE Ratio & Valuation, Is ARDX Overvalued - Intellectia AI

Apr 03, 2026

Apr 02, 2026

Assessing Ardelyx (ARDX) Valuation As New Chief Medical Officer Signals A Fresh Growth Phase - Sahm

Apr 02, 2026

Apr 01, 2026

Support Test: Is Ardelyx Inc stock forming a triangle pattern2026 Big Picture & Expert Verified Stock Movement Alerts - baoquankhu1.vn

Apr 01, 2026

Apr 01, 2026

Ardelyx names Rajani Dinavahi as chief medical officer - Investing.com

Apr 01, 2026

Apr 01, 2026

Ardelyx names Rajani Dinavahi as chief medical officer By Investing.com - Investing.com India

Apr 01, 2026

Apr 01, 2026

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx - The Manila Times

Apr 01, 2026

Apr 01, 2026

Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Rating of "Moderate Buy" from Brokerages - marketbeat.com

Apr 01, 2026

Mar 30, 2026

Trading Action: Can Ardelyx Inc stock double in the next yearMarket Risk Summary & Community Verified Watchlist Alerts - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Tech Rally: Is Ardelyx Inc affected by consumer sentiment2026 Institutional Moves & Technical Buy Zone Confirmation - baoquankhu1.vn

Mar 29, 2026

Mar 27, 2026

Ardelyx Investors Drop Appeal Over U-Turn on Medicare Program - Bloomberg Law News

Mar 27, 2026

Mar 26, 2026

Ardelyx, Inc. Stock Hits Day Low of $5.26 Amid Price Pressure - Markets Mojo

Mar 26, 2026

Mar 26, 2026

[SCHEDULE 13G/A] ARDELYX, INC. Amended Passive Investment Disclosure - stocktitan.net

Mar 26, 2026

Mar 25, 2026

Ardelyx Stock Gaps Down Amid Weak Start and Market Concerns - Markets Mojo

Mar 25, 2026

Mar 25, 2026

Piper Sandler Maintains a Hold Rating on Ardelyx (ARDX) - MSN

Mar 25, 2026

Mar 24, 2026

Ardelyx's post-earnings decline attributed to concerns over Ibsrela outlook - MSN

Mar 24, 2026

Mar 24, 2026

Ardelyx gains after insider purchase, LPGA marketing deal - MSN

Mar 24, 2026

Mar 22, 2026

ARDX SEC FilingsArdelyx 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 22, 2026

Mar 21, 2026

ARDX stock is down pre-market after Q4 earnings miss, so why did this firm just hike price target by 80%? - MSN

Mar 21, 2026

Mar 20, 2026

Can Ardelyx Inc stock outperform in a bear market2026 Short Interest & Stepwise Trade Execution Plans - baoquankhu1.vn

Mar 20, 2026

Mar 19, 2026

ARDX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 19, 2026

Mar 18, 2026

Insider Selling: Ardelyx (NASDAQ:ARDX) CEO Sells 41,666 Shares of Stock - MarketBeat

Mar 18, 2026

Mar 18, 2026

Raab, Ardelyx CEO, sells $243k in ARDX stock By Investing.com - Investing.com South Africa

Mar 18, 2026

Mar 18, 2026

Raab, Ardelyx CEO, sells $243k in ARDX stock - Investing.com

Mar 18, 2026

Mar 18, 2026

Ardelyx (ARDX) CEO exercises options, sells 41,666 shares under plan - Stock Titan

Mar 18, 2026

Mar 18, 2026

Ardelyx, Inc. Opens with 8.38% Gain, Contrasting Recent Performance Trends - Markets Mojo

Mar 18, 2026

Mar 17, 2026

Ardelyx, Inc. Hits Day High with Strong 14.49% Intraday Surge - Markets Mojo

Mar 17, 2026

Mar 16, 2026

ARDX Stock Price, Quote & Chart | ARDELYX INC (NASDAQ:ARDX) - ChartMill

Mar 16, 2026

Mar 14, 2026

Will Ardelyx’s (ARDX) IBSRELA Data Shift Its Competitive Position In IBS-C Treatments? - simplywall.st

Mar 14, 2026

Mar 13, 2026

Leerink Maintains Outperform on Ardelyx, Inc (ARDX) March 12, 2026 - Meyka

Mar 13, 2026

Mar 12, 2026

Leerink Partners reiterates Ardelyx stock rating on pipeline progress - Investing.com

Mar 12, 2026

Mar 12, 2026

Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award - The Manila Times

Mar 12, 2026

Mar 12, 2026

Five kidney disease advocates honored for decades of patient support - Stock Titan

Mar 12, 2026

Mar 11, 2026

Breakout Move: How does Ardelyx Inc correlate with Nasdaq2026 Highlights & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Mar 11, 2026

Mar 11, 2026

Ardelyx Touts IBSRELA’s 73% Growth, Reaffirms $1B 2029 Goal and Details CIC Phase III Plan - MarketBeat

Mar 11, 2026

Mar 10, 2026

Ardelyx at Leerink Conference: Strategic Growth and Pipeline Focus By Investing.com - Investing.com Canada

Mar 10, 2026

Mar 10, 2026

ARDX: IBSRELA targets $1B sales by 2029, with pipeline and commercial growth fueled by strong execution - TradingView

Mar 10, 2026